Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics



Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

indian diabetes market

IMARC’s new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

indian diabetes market report

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report: 

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in India
  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
  • Historical, current and future prevalence of diabetes among males and females in India
  • Historical, current and future prevalence of diabetes among various age groups in India
  • Historical, current and future diagnosis rates for diabetes in India
  • Historical, current and future drug treatment rates for diabetes in India 

Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook 

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook 

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

1 Preface
2 Research Methodology
3 Executive Summary
4 Diabetes Disease Overview

    4.1 What is Diabetes?
    4.2 Diabetes Diagnosis and Treatment
        4.2.1 Diagnosis
        4.2.2 Treatment
    4.3 Diabetes Complications
5 Factors Driving the Diabetes Market in India
    5.1 Increasing Obesity Levels
    5.2 Urbanization
    5.3 India has the Second Largest Diabetes Patient Base in the World
    5.4 India Represents One of the Fastest Growing Markets Globally
    5.5 Improving Diagnosis and Treatment Rates
6 The Indian Diabetes Epidemiology
    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region (Urban and Rural)
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
    6.6 Diabetes Diagnosis and Drug Treatment Rates
7 Indian Diabetes Market
    7.1 Historical Market Trends (2009-2016)
    7.2 Market Breakup by Segment (2009-2016)
    7.3 The Indian Oral Antidiabetics Market
        7.3.1 Historical Market Trends (2009-2016)
        7.3.2 Market Breakup by Class (2009-2016)
        7.3.3 Market Shares of Key Players
        7.3.4 Market Outlook (2017-2021)
    7.4 The Indian Insulin Market
        7.4.1 Historical Market Trends (2017-2021)
        7.4.2 Market Breakup by Class
        7.4.3 Market Shares of Key Players
        7.4.4 Market Outlook (2017-2021)
    7.5 Market Outlook (2017-2021)
8 Indian Diabetes Diagnostics Market
    8.1 Historical Market Trends (2009-2016)
    8.2 Market Segmentation
    8.3 Market Shares of Key Players
    8.4 Market Outlook (2017-2021)
9 SWOT Analysis
    9.1 Strengths
    9.2 Weaknesses
    9.3 Opportunities
    9.4 Threats
10 Value Chain Analysis
11 Porter’s Five Forces
12 Competitive Structure
13 Key Player Profiles
    13.1 Abbott
    13.2 Sanofi
    13.3 Eli Lilly
    13.4 USV
    13.5 Sun Pharma

List of Figures

Figure 4-1: The Impact of Diabetes on the Human Body
Figure 4-2: Diabetes Complications
Figure 4-3: India: Overweight & Obese Population (in Millions), 2009, 2016 & 2021
Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2016 & 2021
Figure 6-1: India: Total Number of Diabetes Patients (in Millions), 2009-2016
Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Millions), 2017–2021
Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2009-2016
Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2017–2021
Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2009-2016
Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Millions), 2017–2021
Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2009-2016
Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2017–2021 
Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2009-2016
Figure 6-10: India: Total Number of Diabetes Patients by Age Group Forecast (20-39), (40-59) & (60-79) (in Millions), 2017–2021
Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2009-2016
Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Millions), 2017–2021
Figure 7-1: India: Diabetes Market (in Million US$), 2009-2016
Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2009-2016
Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2009-2016
Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009-2016
Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2017-2021
Figure 7-7: India: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2016 & 2020
Figure 7-8: India: Insulin Market (in Million US$), 2009-2016
Figure 7-9: India: Insulin Market: Sales Share of Key Classes (in %), 2016
Figure 7-10: India: Insulin Market: Sales Share of Key Players (in %)
Figure 7-11: India: Insulin Market Forecast (in Million US$), 2017-2021
Figure 7-12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2016 & 2021
Figure 7-13: India: Diabetes Market Forecast (in Million US$), 2017-2021
Figure 7-14: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2017-2021
Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2009-2016
Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %),
Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2017-2021
Figure 9-1: Indian: Diabetes Market: SWOT Analysis
Figure 10-1: Indian: Diabetes Market: Value Chain Analysis
 Figure 11-1: Indian: Diabetes Market: Porter’s Five Forces Analysis

List of Tables

Table 2-1: India: Diabetes Epidemiology: Executive Summary
Table 2-2: India: Diabetes Market: Executive Summary
Table 3-1: Diagnosis of Diabetes
Table 4-1: India: Overweight & Obesity Statistics, 2005, 2010 & 2016
Table 4-2: India: Urban & Rural Population Breakup (in Millions), 1992, 2001, 2011
Table 4-3: Global: Diabetes Population Breakup by Country (in 000’s), 2016 & 2021
Table 4-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 5-1: India: Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
Table 5-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
Table 5-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
Table 5-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
Table 5-5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2021
Table 5-6: India: Total Diagnosed & Drug Treated Diabetes Population, 2009, 2016 & 2021


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Intravenous (IV) solutions are a complete mix of essential nutrients which are intended to replenish fluid losses, treat electrolyte imbalances and maintain fluid balance in intravenous therapy.


Body Contouring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Body contouring refers to the process of eliminating or reducing the remaining fat or skin, after a person has lost a significant amount of weight. This excess of fat is mostly present in body parts such as torso, upper arms, chest or thighs.


Protein Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Protein ingredients are consumed to maintain the level of proteins in a human body as they are the best source to keep the body fit. The human body is incapable of producing vital amino acids which are required for healing cells.


Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast pump refers to a medical device which is used for extracting breast milk from lactating women. This not only prevents discomfort but also helps to keep infection at bay while the expressed milk can be used to feed the baby later.


Feminine Hygiene Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Maintaining personal hygiene plays a major role in any female’s reproductive health and quality of life. Feminine hygiene products support proper intimate hygiene practices in order to avoid infection.